ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teramoto, S.
Right arrow Articles by Fukuchi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teramoto, S.
Right arrow Articles by Fukuchi, Y.
Eur Respir J 2001; 17:573-574
Copyright ©ERS Journals Ltd 2001


The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea

S. Teramoto1, H. Kume1, T. Matsuse3 and Y. Fukuchi2

1 International University of Health and Welfare, Dept of Internal Medicine, San-no Hospital, 8-10-16 Akasaka, Minato-ku Tokyo, Japan, 107-0052, 3 Dept of Pulmonary Medicine, Yokohama City University Medical Centre, Yokohama, Japan and 2 Dept of Respiratory Medicine, Juntendo University, Tokyo, Japan, 113-8421

CORRESPONDENCE:

Received: October 27, 2000
Accepted October 27, 2000

To the Editor:

In the recent issue of European Respiratory Journal, Kiely and McNicolas have sophisticatedly demonstrated that the increased risk of future cardiovascular diseases is independent of obstructive sleep apnoea (OSA) in patients with obstructive sleep apnoea syndrome (OSAS) 1. Although many investigators have reported that there is a significant link between OSA and the cardiovascular events, they insisted that the patients with OSAS are at high risk of future cardiovascular diseases from factors, i.e. diabetes mellitus, hypertension, hypothyroidism, hyperlipidemia, other than OSAS. In addition, these independent risk factors of cardiovascular diseases are not associated with OSAS severity, i.e. increasing apnoea/hypopnoea index (AHI) level 1. The results are very interesting, but could not be entirely accepted. It has been reported that OSA is associated with hypertension, independent of the confounding factors of age and obesity and that nondipping of 24 h blood pressure profile is related to apnoea severity 2. Indeed the nocturnal high blood pressure in patients with OSAS is easily controlled by the nasal continuous positive airway pressure, but hardly by ordinary hypertensive therapy 3. Interestingly, Weichler et al. have reported that the treatment of hypertension may reduce the frequency of sleep disordered breathing 4. Furthermore, two recent studies have suggested there is a significant causal relationship between hypertension and sleep-disordered breathing. Peppard et al. reported a dose-response association between sleep-disordered breathing at baseline and the presence of hypertension 4 yrs later, that was independent of known confounding factors 5. They also suggested that persons with minimal sleep-disordered breathing (less than AHI 5) had a higher odds ratio of hypertension than those with no episodes of sleep-disordered breathing. Bixler et al. have also reported that sleep-disordered breathing is independently associated with hypertension when potential confounders including age, BMI, sex, menopause, alcohol use and smoking were controlled for in the logistic regression analysis 6. Although the mechanism of hypertension and cardiovascular events in OSAS patients are not fully elucidated, it has been suggested that abnormalities in cardiovascular variability is implicated in the subsequent development of overt cardiovascular disease in patients with OSA 7. It has recently been reported that blood pressure measured in young adult men is positively associated with increased cardiovascular mortality in later life 8.

Considered together, it is reasonable to speculate that OSA per se contributes to raised blood pressure in adulthood, and is implicated in the pathogenesis of cardiovascular events in later life.

References

  1. Kiely JL, McNicholas WT. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000;16:128–133.[Abstract]
  2. Pankow W, Nabe B, Lies A, et al. Influence of sleep apnea on 24-hour blood pressure. Chest 1997;112:1253–1258.[Abstract/Free Full Text]
  3. Teramoto S, Ohga E, Ouchi Y. Obstructive sleep apnoea. Lancet 2000;355:1213–1214.
  4. Weichler U, Herres-Meyer B, Meyer K, et al. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 1999;78:124–130.
  5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378–1384.[Abstract/Free Full Text]
  6. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000;160:2289–2295.[Abstract/Free Full Text]
  7. Teramoto S, Matsuse T, Ouchi Y. Does the altered cardiovascular variability in association with obstructive sleep apnea contribute to development of cardiovascular disease in patients with obstructive sleep apnea syndrome? [letter]. Circulation 1999;100:e136–e137.[Free Full Text]
  8. McCarron P, Smith GD, Okasha M, McEwen J. Blood pressure in young adulthood and mortality from cardiovascular disease. Lancet 2000;355:1430–1431.[CrossRef][ISI][Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
ChestHome page
S. Teramoto, H. Yamamoto, Y. Yamaguchi, R. Namba, and Y. Ouchi
Obstructive Sleep Apnea Causes Systemic Inflammation and Metabolic Syndrome
Chest, March 1, 2005; 127(3): 1074 - 1075.
[Full Text] [PDF]


Home page
ChestHome page
S. Teramoto, H. Yamamoto, Y. Ouchi, K.-i. Inoue, H. Takano, and T. Yoshika
Increased Plasma Interleukin-6 Is Associated With the Pathogenesis of Obstructive Sleep Apnea Syndrome
Chest, May 1, 2004; 125(5): 1964 - 1965.
[Full Text] [PDF]


Home page
Eur Respir JHome page
S. Teramoto, H. Kume, T. Matsuse, T. Ishii, and Y. Inoue
Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms
Eur. Respir. J., December 1, 2001; 18(6): 1077 - 1077.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teramoto, S.
Right arrow Articles by Fukuchi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teramoto, S.
Right arrow Articles by Fukuchi, Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS